Wells Fargo’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Sell
32,106
-26,575
-45% -$1.82M ﹤0.01% 3175
2025
Q4
$3.47M Buy
58,681
+16,950
+41% +$920K ﹤0.01% 3002
2025
Q3
$2.3M Buy
41,731
+3,135
+8% +$163K ﹤0.01% 3217
2025
Q2
$1.66M Buy
38,596
+1,373
+4% +$53K ﹤0.01% 3357
2025
Q1
$1.47M Buy
37,223
+168
+0.5% +$7.43K ﹤0.01% 3401
2024
Q4
$1.51M Buy
37,055
+11,742
+46% +$489K ﹤0.01% 3407
2024
Q3
$987K Sell
25,313
-26,580
-51% -$1.06M ﹤0.01% 3554
2024
Q2
$2.27M Sell
51,893
-8,956
-15% -$433K ﹤0.01% 2885
2024
Q1
$2.9M Buy
60,849
+8,224
+16% +$370K ﹤0.01% 2674
2023
Q4
$2.48M Sell
52,625
-10,181
-16% -$423K ﹤0.01% 2733
2023
Q3
$2.99M Sell
62,806
-11,444
-15% -$625K ﹤0.01% 2481
2023
Q2
$4.32M Buy
74,250
+9,330
+14% +$560K ﹤0.01% 2268
2023
Q1
$4.64M Buy
64,920
+5,296
+9% +$420K ﹤0.01% 2175
2022
Q4
$4.2M Sell
59,624
-525
-0.9% -$37K ﹤0.01% 2215
2022
Q3
$3.65M Sell
60,149
-1,161
-2% -$77.9K ﹤0.01% 2232
2022
Q2
$3.87M Sell
61,310
-25,439
-29% -$1.66M ﹤0.01% 2282
2022
Q1
$5.56M Sell
86,749
-5,417
-6% -$362K ﹤0.01% 2368
2021
Q4
$6.61M Sell
92,166
-69,199
-43% -$5.26M ﹤0.01% 2277
2021
Q3
$11.5M Sell
161,365
-2,293
-1% -$181K ﹤0.01% 2079
2021
Q2
$13.3M Sell
163,658
-13,356
-8% -$1.07M ﹤0.01% 1993
2021
Q1
$13.4M Sell
177,014
-106,923
-38% -$7.78M ﹤0.01% 1969
2020
Q4
$21.5M Sell
283,937
-310,818
-52% -$20.2M 0.01% 1507
2020
Q3
$29.4M Sell
594,755
-240,476
-29% -$13.6M 0.01% 1163
2020
Q2
$43.9M Buy
835,231
+571,334
+216% +$27.1M 0.01% 913
2020
Q1
$9.29M Sell
263,897
-692,424
-72% -$40.4M ﹤0.01% 1727
2019
Q4
$83.6M Sell
956,321
-114,320
-11% -$10M 0.02% 679
2019
Q3
$90.8M Sell
1,070,641
-2,853
-0.3% -$254K 0.03% 607
2019
Q2
$113M Buy
1,073,494
+28,942
+3% +$2.91M 0.03% 525
2019
Q1
$110M Sell
1,044,552
-83,699
-7% -$8.41M 0.03% 510
2018
Q4
$94.4M Buy
1,128,251
+351,352
+45% +$31.8M 0.03% 530
2018
Q3
$79.2M Buy
776,899
+683,611
+733% +$66M 0.02% 690
2018
Q2
$7.54M Sell
93,288
-29,003
-24% -$2.3M ﹤0.01% 2299
2018
Q1
$9.01M Sell
122,291
-109,335
-47% -$8.18M ﹤0.01% 2108
2017
Q4
$16.3M Sell
231,626
-129,977
-36% -$9.38M ﹤0.01% 1608
2017
Q3
$22.6M Buy
361,603
+58,989
+19% +$3.49M 0.01% 1332
2017
Q2
$17.4M Buy
302,614
+230,558
+320% +$13.6M 0.01% 1482
2017
Q1
$4.38M Buy
72,056
+37,259
+107% +$2.11M ﹤0.01% 2535
2016
Q4
$1.91M Buy
34,797
+13,840
+66% +$664K ﹤0.01% 3198
2016
Q3
$966K Buy
20,957
+421
+2% +$17.8K ﹤0.01% 3516
2016
Q2
$699K Buy
+20,536
New +$641K ﹤0.01% 3713

Other funds holding NGVT

Wells Fargo's NGVT Position: Q1 2026 in Review

Wells Fargo reduced its Ingevity (NGVT) stake by 45% in Q1 2026, selling an estimated $1.82M and leaving 32,106 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

Wells Fargo first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $113M in Q2 2019. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Wells Fargo held 32,106 shares of Ingevity worth $2.29M as of Q1 2026.
  • Wells Fargo sold 26,575 Ingevity shares in Q1 2026, an estimated $1.82M.
  • Ingevity made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3175 holding.
  • Wells Fargo first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
  • Wells Fargo's Ingevity position peaked at $113M in Q2 2019.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.